Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation

NCT00375323 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: NovoSeven

Sponsor

Medical University of Vienna